Professor Ricky Johnstone is the Head of the Gene Regulation Laboratory at the Peter MacCallum Cancer Centre and the Head, The Sir Peter MacCallum Department of Oncology, The University of Melbourne. He is the recipient
Wonderful to see the FDA, TGA and Canadian regulatory authorities working together to approve a new treatment for refractory/ relapsed Chronic Lymphocytic Leukaemia (CLL). Acalabrutinib is a second-generation BTK (Bruton’s tyrosine kinase or tyrosine-protein kinase)
Andrea grew up in Melbourne and has over 20 years experience in senior leadership positions working with organisations like Nike Australia. Andrea relocated to WA with her family and currently manages the WA Chapter of
Kaz should have been snuggling into her newborn baby, gazing into her eyes as she fed but instead, she was being infused with chemotherapy. A substance so toxic she couldn’t even hold her beautiful baby
In a very short period of time Blood Cancer Research WA, supported by the Snowdome Foundation, has managed to increase the number of blood cancer patients on clinical trials by almost 100 and reduce the
Dr Pilar Dominguez is a senior postdoctoral researcher working with Prof Ricky Johnstone at the Peter MacCallum Cancer Centre. Her research is focused on the role that abnormal epigenetics processes play in lymphoma formation with
It is disappointing to learn that the Medical Services Advisory Committee did not find in favour of funding tisagenlecleucel a chimeric antigen receptor T-cell (CAR T-cell) therapy for diffuse large B-cell lymphoma (DLBCL). The committee
This time last week the Snowdome Foundation and Blood Cancer Research WA hosted ‘Blood, Sweat and Tears of Joy’ an educational evening bringing together clinicians, researchers, patients and supporters. The premise behind Blood Cancer Research
Paul Mutimer had niggling back pain and was constantly tired, but he felt it was due to his workload as a psychologist and his age. At 57 being tired and suffering some back pain is
Assoc Prof Chan Cheah is passionate and driven. He wants blood cancer patients in Western Australia to have the same opportunity to access new treatments as patients in other parts of Australia. He knows too
